An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early Stage Triple-Negative Breast Cancer

Scientists CRISPR-engineered RNA splice junctions to produce normal and early stage ductal carcinoma in situ breast epithelial cells that expressed only AIB1Δ4. These cells showed enhanced motility and invasion in 3D cell culture.